miR-181a下调可上调去乙酰化酶-1(SIRT1)并改善肝脏胰岛素敏感性

Zhai, Q.W.; Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai, Chinese Academy of Sciences, 294 Taiyuan Road, Shanghai 200031, China; email:qwzhai@sibs.ac.cn

Aims/hypothesis: Sirtuin-1 (SIRT1) is a potential therapeutic target to combat insulin resistance and type 2 diabetes. This study aims to identify a microRNA (miRNA) targeting SIRT1 to regulate hepatic insulin sensitivity. Methods: Luciferase assay combined with mutation and im-munoblotting was used to screen and verify the bioinfor-matically predicted miRNAs. miRNA and mRNA levels were measured by real-time PCR. Insulin signalling was detected by immunoblotting and glycogen synthesis. Involvement of SIRT1 was studied with adenovirus, inhibitor and SIRT1-deficient hepatocytes. The role of miR-181a in vivo was explored with adenovirus and locked nucleic acid antisense oligonucleotides. Results: miR-181a targets the 3' untranslated region (3'UTR) of Sirt1 mRNA through a miR-181a binding site, and down-regulates SIRT1 protein abundance at the translational level. miR-181a is increased in insulin-resistant cultured hepato-cytes and liver, and in the serum of diabetic patients. Over-expression of miR-181a decreases SIRT1 protein levels and activity, and causes insulin resistance in hepatic cells. Inhibition of miR-181a by antisense oligonucleotides increases SIRT1 protein levels and activity, and improves insulin sensitivity in hepatocytes. Ectopic expression of SIRT1 abrogates the effect of miR-181a on insulin sensitivity, and inhibition of SIRT1 activity or SIRT1 deficiency markedly attenuated the improvement in insulin sensitivity induced by antisense miR-181a. In addition, overexpression of miR-181a by adenovirus impairs hepatic insulin signalling, and intraperitoneal injection of locked nucleic acid antisense oligonucleotides for miR-181a improves glucose homeostasis in diet-induced obesity mice. Conclusions/interpretation: miR-181a regulates SIRT1 and improves hepatic insulin sensitivity. Inhibition of miR-181a might be a potential new strategy for treating insulin resistance and type 2 diabetes. © springer-verlag 2012.

Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai, Chinese Academy of Sciences, 294 Taiyuan Road, Shanghai 200031, China